To improve the performance of our website, show the most relevant news products and targeted advertising, we collect technical impersonal information about you, including through the tools of our partners. You can find a detailed description of how we use your data in our Privacy Policy. For a detailed description of the technologies, please see the Cookie and Automatic Logging Policy.

By clicking on the "Accept & Close" button, you provide your explicit consent to the processing of your data to achieve the above goal.

You can withdraw your consent using the method specified in the Privacy Policy.

Although it has become perfectly legal to treat certain diseases with "green relief" in Denmark, doctors have been reluctant to avail themselves of this opportunity, forcing patients to revert to street pushers to procure the much sought-after drug.

Denmark's trial of medicinal cannabis, in which the green drug may be legally prescribed to sufferers of multiple sclerosis (MS), chronic nervous pain or receive chemotherapy, has been challenged by the medical community's reluctance to prescribe it, citing insufficient research, the Finnish Hufvudstadsbladet daily reported.

"There is insufficient evidence of the drug's efficiency, possible side effects, interactions with other drugs and long-term effects," the chairman of the Danish Medical Association, Andreas Rudkjøbing, told Hufvudstadsbladet.

According to Rudkjøbing, Danish media have treated the issue of medical cannabis in an uncritical way, resulting in an unabashed lobbying campaign. Although Denmark's medical circles voiced their skepticism in advance, a parliamentary majority nevertheless voted in favor of the proposal.

"This is a political project they have started in Denmark. There is no scientific support for taking cannabis as a drug as of now," Rudkjøbing argued.

According to polls, the majority of Danes (88 percent) supports the idea of medicinal cannabis and is hopeful that it would become the first step toward legalizing the drug for good.

The debate about medical cannabis has been going on for several years in Denmark. To bring the situation out of a dead-end, the Medical Association proposed an arrangement with clinical research on patients.

"Hereby, we would ensure that there is enough cannabis to those involved. Also, it would be done safely and patients would be followed up frequently and we would get more of the needed research. But politicians have not taken our proposal seriously," Rudkjøbing argued.

The government's push for medicinal cannabis in absence of reliable medical research has resulted in patients rolling back to the black market.

One of them is 39-year-old Thomas Pedersen, who resorts to smoking cannabis to relieve the excruciatingly painful MS symptoms, such as intense pain, spasms and tremors, to be able to work part-time. According to him, common drugs don't work that well. By his own admission, Pedersen used to procure his relief drug in Christiania, Copenhagen's famous hippy district.

"I'd rather have it by prescription, than being a criminal and supporting the black market. But I'm forced to do it when I do not get it by prescription," Pedersen acknowledged. "Some people in the government haven't thought properly before making this agreement," he said.

At present, medicinal cannabis is imported from the Netherlands and sold in the form of oil and tea.

Despite the initial fiasco, there are plans to make Denmark one of the world's leading manufacturers of medicinal cannabis, and 15 companies have already applied for license to grow hemp.

In 2013, Uruguay became the first country in the world to fully legalize the sale, cultivation and distribution of marijuana. The medicinal use of cannabis is legal in a number of countries, including Canada, Australia, the Czech Republic and Israel, as well as 29 US states.

By clicking the "Post" button, you provide your explicit consent to the processing of your Facebook account data to enable you to comment to the news on our website using this account. You can find a detailed description of how we use your data in our Privacy Policy.

By checking this box, you provide your explicit consent to the processing of your personal data to create an account on the Sputnik website for posting comments to news. You can find a detailed description of how we use your data in our Privacy Policy.
You can withdraw your consent by using the feedback form or the method specified in the Privacy Policy.

* All fields are required

Please confirm your e-mail to continue. Confirmation instructions have been sent to

Hello,
!

We are committed to protecting your personal information and we have updated our Privacy Policy to comply with the General Data Protection Regulation (GDPR), a new EU regulation that went into effect on May 25, 2018.

Please review our Privacy Policy. It contains details about the types of data we collect, how we use it, and your data protection rights.

Since you already shared your personal data with us when you created your personal account, to continue using it, please check the box below:

I agree to the processing of my personal data for the purpose of creating a personal account on this site, in compliance with the Privacy Policy.

If you do not want us to continue processing your data, please click here to delete your account.

promotes the use of narcotic / psychotropic substances, provides information on their production and use;

contains links to viruses and malicious software;

is part of an organized action involving large volumes of comments with identical or similar content ("flash mob");

“floods” the discussion thread with a large number of incoherent or irrelevant messages;

violates etiquette, exhibiting any form of aggressive, humiliating or abusive behavior ("trolling");

doesn’t follow standard rules of the English language, for example, is typed fully or mostly in capital letters or isn’t broken down into sentences.

The administration has the right to block a user’s access to the page or delete a user’s account without notice if the user is in violation of these rules or if behavior indicating said violation is detected.